Edwards Lifesciences announces $750M accelerated share repurchase, initial ~8M shares

Edwards Lifesciences Corp

$750M ASR executed; initial delivery of ~8M shares, remainder based on VWAP over term.
Total 2022 repurchases exceed $1.7 billion.
Approximately $900 million remains in board-authorized repurchase plan.
Repurchase funded with existing cash.

item 8.01 item 9.01

Edwards Lifesciences Corp filing history →

Source: SEC EDGAR

accession 0001193125-22-274553

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.